Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PHYT Stock Summary
In the News
PHYT Financial details
Company Rating
Buy
Market Cap
158.54M
Income
11.48M
Revenue
0
Book val./share
13.23
Cash/share
15.19
Dividend
-
Dividend %
-
Employees
2
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
4.84
Forward P/E
-
PEG
0.07
P/S
-
P/B
0.66
P/C
0.74
P/FCF
-328.83
Quick Ratio
77.39
Current Ratio
0.43
Debt / Equity
0.01
LT Debt / Equity
-
-
-
EPS (TTM)
0.74
EPS next Y
-
EPS next Q
-
EPS this Y
862.51%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
31.25%
-
-
-
-
SMA20
1.44%
SMA50
1.99%
SMA100
3.21%
Inst Own
126.94%
Inst Trans
0.74%
ROA
12%
ROE
8%
ROC
-0.02%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
10.53-11.32
52W High
+2.73%
52W Low
+13%
RSI
70.02
Rel Volume
1.9
Avg Volume
27.33K
Volume
51.79K
Perf Week
1.44%
Perf Month
1.71%
Perf Quarter
-
Perf Half Y
3.48%
-
-
-
-
Beta
0.002
-
-
Volatility
0.02%, 0.08%
Prev Close
0%
Price
11.3
Change
0%
PHYT Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2021-12-31 | 2022-12-31 |
---|---|---|---|
2.02K | 2.02K | ||
Revenue per share | 0 | 0 | |
Net income per share | 0.1 | 0.95 | |
Operating cash flow per share | -0.01 | -0.04 | |
Free cash flow per share | -0.01 | -0.04 | |
Cash per share | 0.04 | 8.33 | |
Book value per share | 7.47 | 7.89 | |
Tangible book value per share | 7.47 | 7.89 | |
Share holders equity per share | 7.47 | 7.89 | |
Interest debt per share | -0.11 | -0.53 | |
Market cap | 248.29M | 259.86M | |
Enterprise value | 247.33M | 259.85M | |
P/E ratio | 99.95 | 10.83 | |
Price to sales ratio | 0 | 0 | |
POCF ratio | -1.33K | -279.78 | |
PFCF ratio | -1.33K | -279.78 | |
P/B Ratio | 1.32 | 1.31 | |
PTB ratio | 1.32 | 1.31 | |
EV to sales | 0 | 0 | |
Enterprise value over EBITDA | -710.97 | -16.2 | |
EV to operating cash flow | -1.32K | -279.76 | |
EV to free cash flow | -1.32K | -279.76 | |
Earnings yield | 0.01 | 0.09 | |
Free cash flow yield | 0 | 0 | |
Debt to equity | 0 | 0 | |
Debt to assets | 0 | 0 | |
Net debt to EBITDA | 2.78 | 0 | |
Current ratio | 10.43 | 1.63 | |
Interest coverage | 0.12 | 0.2 | |
Income quality | -0.08 | -0.09 | |
Dividend Yield | 0 | 0 | |
Payout ratio | 0.01 | 0 | |
Sales general and administrative to revenue | 0 | 0 | |
Research and developement to revenue | 0 | 0 | |
Intangibles to total assets | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | |
Capex to revenue | 0 | 0 | |
Capex to depreciation | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | |
Graham number | 4.07 | 13.01 | |
ROIC | 0 | -0.03 | |
Return on tangible assets | 0.01 | 0.11 | |
Graham Net | -0.75 | 7.88 | |
Working capital | 1.23M | 139.27K | |
Tangible asset value | 187.87M | 198.51M | |
Net current asset value | -18.72M | -11.14M | |
Invested capital | 0 | 0 | |
Average receivables | 0 | 37.25K | |
Average payables | 0 | 0 | |
Average inventory | 0 | 169.8K | |
Days sales outstanding | 0 | 0 | |
Days payables outstanding | 0 | 0 | |
Days of inventory on hand | 0 | 0 | |
Receivables turnover | 0 | 0 | |
Payables turnover | 0 | 0 | |
Inventory turnover | 0 | 0 | |
ROE | 0.01 | 0.12 | |
Capex per share | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0.3 | 0.27 | 0.1 | 0.16 | 0.21 | |
Operating cash flow per share | 0 | -0.01 | 0 | -0.01 | -0.02 | |
Free cash flow per share | 0 | -0.01 | 0 | -0.01 | -0.02 | |
Cash per share | 8.27 | 0 | 8.43 | 15.89 | 15.19 | |
Book value per share | 7.77 | 7.89 | 7.93 | 13.76 | 13.23 | |
Tangible book value per share | 7.77 | 7.89 | 7.93 | 13.76 | 13.23 | |
Share holders equity per share | 7.77 | 7.89 | 7.93 | 13.76 | 13.23 | |
Interest debt per share | -0.31 | -0.15 | -0.06 | 0.04 | 0.1 | |
Market cap | 255.34M | 259.86M | 264.39M | 64.12M | 69.75M | |
Enterprise value | 255.07M | 259.85M | 264.39M | 64.35M | 70.41M | |
P/E ratio | 8.56 | 9.71 | 27.06 | 16.3 | 12.8 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -2.82K | -974.36 | -20.8K | -894.09 | -585.81 | |
PFCF ratio | -2.82K | -974.36 | -20.8K | -894.09 | -585.81 | |
P/B Ratio | 1.31 | 1.31 | 1.33 | 0.77 | 0.82 | |
PTB ratio | 1.31 | 1.31 | 1.33 | 0.77 | 0.82 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -62.08 | -59.81 | -141.34 | -29.61 | -28.66 | |
EV to operating cash flow | -2.82K | -974.31 | -20.8K | -897.31 | -591.31 | |
EV to free cash flow | -2.82K | -974.31 | -20.8K | -897.31 | -591.31 | |
Earnings yield | 0.03 | 0.03 | 0.01 | 0.02 | 0.02 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0.01 | |
Debt to assets | 0 | 0 | 0 | 0 | 0.01 | |
Net debt to EBITDA | 0.06 | 0 | 0 | -0.11 | -0.27 | |
Current ratio | 8.38 | 1.63 | 0.72 | 0.21 | 0.43 | |
Interest coverage | 0.03 | 0.18 | 0.3 | 0 | 0 | |
Income quality | -0.03 | -0.09 | -0.01 | -0.07 | -0.09 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 7.2 | 6.87 | 4.16 | 7.11 | 7.96 | |
ROIC | 0 | -0.01 | -0.01 | -0.01 | -0.01 | |
Return on tangible assets | 0.04 | 0.03 | 0.01 | 0.01 | 0.01 | |
Graham Net | 7.75 | -0.46 | 7.92 | 13.73 | 13.2 | |
Working capital | 598.84K | 139.27K | -91.6K | -626.49K | -722.99K | |
Tangible asset value | 195.49M | 198.51M | 199.51M | 82.75M | 84.59M | |
Net current asset value | -12.22M | -11.14M | -12.49M | -12.81M | -12.52M | |
Invested capital | 0 | 0 | 0 | 0 | 0.01 | |
Average receivables | 19.75K | 44.5K | 39K | 14.25K | 240K | |
Average payables | 0 | 0 | 3.76K | 7.51K | 35.68K | |
Average inventory | -19.75K | -19.75K | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.04 | 0.03 | 0.01 | 0.01 | 0.02 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
PHYT Frequently Asked Questions
What is Pyrophyte Acquisition Corp. stock symbol ?
Pyrophyte Acquisition Corp. is a US stock , located in Houston of Tx and trading under the symbol PHYT
What is Pyrophyte Acquisition Corp. stock quote today ?
Pyrophyte Acquisition Corp. stock price is $11.3 today.
Is Pyrophyte Acquisition Corp. stock public?
Yes, Pyrophyte Acquisition Corp. is a publicly traded company.